NCT04076852

Brief Summary

This retrospective and prospective observational study intends to evaluate the correlation between seasons and the variation of the syndromic structure of the Tourette.

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
39

participants targeted

Target at P25-P50 for all trials

Timeline
Completed

Started Apr 2018

Geographic Reach
1 country

1 active site

Status
terminated

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

April 6, 2018

Completed
9 months until next milestone

First Submitted

Initial submission to the registry

December 29, 2018

Completed
5 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 31, 2019

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

May 31, 2019

Completed
3 months until next milestone

First Posted

Study publicly available on registry

September 3, 2019

Completed
Last Updated

May 9, 2023

Status Verified

August 1, 2019

Enrollment Period

1.2 years

First QC Date

December 29, 2018

Last Update Submit

May 8, 2023

Conditions

Outcome Measures

Primary Outcomes (1)

  • Change from baseline Y-GTSS score at 6 months.

    The primary objective is to investigate the correlation between seasons and different phenotypic variation through the administration of a specific questionnaire (Y-GTSS) and questions about the subjective perception of the ticcogenic variation.

    4, 8, 12 months.

Secondary Outcomes (1)

  • Change from baseline Y-BOCS score at 6 months.

    4, 8, 12 months.

Interventions

According to clinical practice, the following questionnaires are administered: * Y-GTSS * Y-BOCS or cY-BOCS

Eligibility Criteria

Age6 Years - 50 Years
Sexall
Age GroupsChild (0-17), Adult (18-64)
Sampling MethodProbability Sample
Study Population

Being a pilot study it was not possible to develop a sample study, but the sample number is designed based on the tourette center turnout

You may qualify if:

  • Patients attending the Tourette Center since January 2012.
  • Males and females.
  • Age between 6 and 50 (completed).
  • Diagnosis of Tourette syndrome ascertained
  • Presence of a value equal to or greater than 15/40 of the Y-BOCS.

You may not qualify if:

  • Presence of allergic pathology.
  • Presence of significant psychiatric symptoms, with the exception of those belonging to the Tourette Syndrome itself (eg ADHD, OCD)

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

IRCCS Galeazzi Hospital

Milan, Lombardy, 20161, Italy

Location

MeSH Terms

Conditions

Tourette Syndrome

Condition Hierarchy (Ancestors)

Basal Ganglia DiseasesBrain DiseasesCentral Nervous System DiseasesNervous System DiseasesTic DisordersMovement DisordersHeredodegenerative Disorders, Nervous SystemNeurodegenerative DiseasesGenetic Diseases, InbornCongenital, Hereditary, and Neonatal Diseases and AbnormalitiesNeurodevelopmental DisordersMental Disorders

Study Officials

  • Mauro Porta

    IRCCS Orthopedic Institute Galeazzi

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
OTHER
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

December 29, 2018

First Posted

September 3, 2019

Study Start

April 6, 2018

Primary Completion

May 31, 2019

Study Completion

May 31, 2019

Last Updated

May 9, 2023

Record last verified: 2019-08

Locations